PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

Biotechnology

Healthcare
$1.31 +3.91%

+$0.04 today

Market cap
$69.86M
Beta
1.36
P/E (TTM)
-0.8
EPS (TTM)
-$1.47
52W Low $0.96High $1.88

Volume 1.19M

Average 0.38M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$86.21M

FY 2025 · Annual

Net Income

-$77.74M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue1.28M650K1.26M1.14M0
Gross Profit(1.28M)(650K)(1.26M)(1.14M)0
Gross Margin—————
Research & Development36.19M51.67M54.63M57.38M69.88M
Selling, General & Admin20.83M24.72M24.25M26.92M16.33M
Operating Expenses57.01M76.39M78.88M84.3M86.21M
Depreciation & Amortization1.28M650K1.26M1.14M133K
EBITDA(56.54M)(72.68M)(67.7M)(73.67M)(79.78M)
EBITDA Margin—————
Operating Income(58.29M)(77.04M)(80.13M)(85.45M)(86.21M)
Operating Margin—————
Interest Income449K3.63M11.17M10.66M6.34M
Interest Expense00000
Other Income / Expenses470K3.71M11.17M10.64M6.29M
Income Before Tax(57.82M)(73.33M)(68.96M)(74.81M)(79.91M)
Pre-Tax Margin—————
Income Tax Expense23K(9K)2K(16.1M)(2.17M)
Net Income(57.85M)(73.32M)(68.96M)(58.71M)(77.74M)
Net Margin—————
EPS (Basic)(1.28)(1.61)(1.44)(1.14)(1.48)
EPS (Diluted)(1.28)(1.61)(1.44)(1.14)(1.48)
Weighted Avg Shares45.14M45.59M48.01M51.58M52.54M
Weighted Avg Shares (Diluted)45.14M45.59M48.01M51.58M52.54M

PMVP Earnings Waterfall · TTM

NASDAQ:PMVP · Revenue to Net Income

Key Ratios

EPS$-1.49
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-0.8
P/S Ratio0.0

Analysis

$0 of revenue converted into -$78.3M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-1.49, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 10, 2026
10-QQuarterly reportNov 10, 2026
4Statement of changes in beneficial ownershipOct 5, 2026
3Initial statement of beneficial ownershipOct 5, 2026
8-KCurrent reportOct 5, 2026

How much revenue does PMVP generate?

PMV Pharmaceuticals, Inc. (PMVP) reported $0.00 of revenue in fiscal 2025.

Is PMVP profitable?

PMV Pharmaceuticals, Inc. (PMVP) reported -$77.74M of net income.